Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
Acta Diabetologica
Published in: Acta Diabetologica 1/2003

01-10-2003 | ORIGINAL

Body composition in coeliac disease adolescents on a gluten-free diet: a longitudinal study

Authors: M. C. Carbone, G. Pitzalis, M. Ferri, R. Nenna, E. Thanasi, A. Andreoli, A. De Lorenzo, M. Bonamico

Published in: Acta Diabetologica | Special Issue 1/2003

Login to get access
Metadata
Title
Body composition in coeliac disease adolescents on a gluten-free diet: a longitudinal study
Authors
M. C. Carbone
G. Pitzalis
M. Ferri
R. Nenna
E. Thanasi
A. Andreoli
A. De Lorenzo
M. Bonamico
Publication date
01-10-2003
Publisher
Springer-Verlag
Published in
Acta Diabetologica / Issue Special Issue 1/2003
Print ISSN: 0940-5429
Electronic ISSN: 1432-5233
DOI
https://doi.org/10.1007/s00592-003-0057-3

Other articles of this Special Issue 1/2003

Acta Diabetologica 1/2003 Go to the issue

ORIGINAL

Some adventures in body composition, with special reference to nutrition

ORIGINAL

Genetics of food intake and body composition: lessons from twin studies

ORIGINAL

Validity of body composition methods across ethnic population groups

ORIGINAL

Predicting fat-free mass in children using bioimpedance analysis

ORIGINAL

Body composition and bone mineralization measurement in calves of different genetic origin by using dual-energy X-ray absorptiometry

ORIGINAL

Body composition modification in obese patients treated with intragastric balloon
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits